Study Evaluating the Safety & Efficacy of DVS-223 SR for Relief of Vasomotor Symptoms Associated With Menopause
Clinical trial NCT00421031 · COMPLETED
Trial details
- NCT number
- NCT00421031
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-12-01
- Enrollment
- 540
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.